China
· Delayed Price · Currency is CNY Jianerkang Medical Statistics
Total Valuation
SHA:603205 has a market cap or net worth of CNY 4.78 billion. The enterprise value is 4.03 billion.
| Market Cap | 4.78B |
| Enterprise Value | 4.03B |
Important Dates
The last earnings date was Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603205 has 120.00 million shares outstanding. The number of shares has increased by 13.76% in one year.
| Current Share Class | 120.00M |
| Shares Outstanding | 120.00M |
| Shares Change (YoY) | +13.76% |
| Shares Change (QoQ) | +10.47% |
| Owned by Insiders (%) | 66.00% |
| Owned by Institutions (%) | 0.92% |
| Float | 31.80M |
Valuation Ratios
The trailing PE ratio is 32.88.
| PE Ratio | 32.88 |
| Forward PE | n/a |
| PS Ratio | 4.45 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 3.43 |
| P/FCF Ratio | 63.93 |
| P/OCF Ratio | 41.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.08, with an EV/FCF ratio of 53.93.
| EV / Earnings | 32.51 |
| EV / Sales | 3.75 |
| EV / EBITDA | 24.08 |
| EV / EBIT | 32.36 |
| EV / FCF | 53.93 |
Financial Position
The company has a current ratio of 10.28
| Current Ratio | 10.28 |
| Quick Ratio | 8.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 24,421.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 8.39% |
| Revenue Per Employee | 656,148 |
| Profits Per Employee | 75,743 |
| Employee Count | 1,559 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 37.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 56.43 |
| Average Volume (20 Days) | 5,140,661 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603205 had revenue of CNY 1.07 billion and earned 124.07 million in profits. Earnings per share was 1.21.
| Revenue | 1.07B |
| Gross Profit | 246.09M |
| Operating Income | 124.62M |
| Pretax Income | 142.23M |
| Net Income | 124.07M |
| EBITDA | 167.50M |
| EBIT | 124.62M |
| Earnings Per Share (EPS) | 1.21 |
Balance Sheet
The company has 747.87 million in cash and n/a in debt, giving a net cash position of 747.87 million or 6.23 per share.
| Cash & Cash Equivalents | 747.87M |
| Total Debt | n/a |
| Net Cash | 747.87M |
| Net Cash Per Share | 6.23 |
| Equity (Book Value) | 1.45B |
| Book Value Per Share | 12.09 |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was 115.59 million and capital expenditures -40.81 million, giving a free cash flow of 74.78 million.
| Operating Cash Flow | 115.59M |
| Capital Expenditures | -40.81M |
| Free Cash Flow | 74.78M |
| FCF Per Share | 0.62 |
Margins
Gross margin is 22.90%, with operating and profit margins of 11.60% and 11.54%.
| Gross Margin | 22.90% |
| Operating Margin | 11.60% |
| Pretax Margin | 13.23% |
| Profit Margin | 11.54% |
| EBITDA Margin | 15.58% |
| EBIT Margin | 11.60% |
| FCF Margin | 6.96% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.88%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 0.88% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.76% |
| Shareholder Yield | -12.88% |
| Earnings Yield | 2.60% |
| FCF Yield | 1.56% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603205 has an Altman Z-Score of 22.56.
| Altman Z-Score | 22.56 |
| Piotroski F-Score | n/a |